Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Yixuan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7317-7235; OpenAlex author ID A5100396611. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2021: 3 papers · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 7

  1. CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
  2. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mc.23554↗
  3. Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2023.101792↗
  4. Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis. Co-author DOI 10.1039/d2bm00770c↗
  5. Analysis of T-cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases. Co-author DOI 10.1111/jcmm.16358↗
  6. Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer. Co-author DOI 10.2147/cmar.s330473↗
  7. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer. First author DOI 10.3389/fonc.2021.628346↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoping Zou · 6 shared papers, 2021–2023 · strength 0.78
  2. Shu Zhang · 5 shared papers, 2021–2023 · strength 0.66
  3. Shanshan Shen · 4 shared papers, 2021–2023 · strength 0.57
  4. Ying Lv · 4 shared papers, 2021–2023 · strength 0.56
  5. Hui Wang · 3 shared papers, 2021–2023 · strength 0.38
  6. Siqi Zhou · 3 shared papers, 2021–2022 · strength 0.36
  7. Lei Wang · 2 shared papers, 2021 · strength 0.22
  8. Ying Lv · 2 shared papers, 2021 · strength 0.22
  9. Wei Wei · 1 shared paper, 2025 · strength 0.20
  10. Jiatong Tang · 1 shared paper, 2025 · strength 0.20
  11. Neng Tang · 1 shared paper, 2025 · strength 0.20
  12. Chao Yan · 1 shared paper, 2025 · strength 0.20
  13. Hexing Hang · 1 shared paper, 2025 · strength 0.20
  14. Yudong Qiu · 1 shared paper, 2025 · strength 0.20
  15. Hao Cheng · 1 shared paper, 2025 · strength 0.20
  16. Qiang Zhan · 1 shared paper, 2023 · strength 0.17
  17. Cheng Hang · 1 shared paper, 2023 · strength 0.16
  18. Hao Wu · 1 shared paper, 2023 · strength 0.16
  19. Lei Wang · 1 shared paper, 2022 · strength 0.13
  20. Jing Zhao · 1 shared paper, 2022 · strength 0.13
  21. Jing Zhao · 1 shared paper, 2021 · strength 0.12
  22. Dongming Zhu · 1 shared paper, 2021 · strength 0.11
  23. Jie An Yang · 1 shared paper, 2021 · strength 0.11
  24. Xin Gao · 1 shared paper, 2021 · strength 0.11
  25. Jie Yang · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.